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effectiveness of herbal medicines in diabetes mellitus. Many 
of the commonly used phytomedicines have been evaluated 
by scientists for anti-diabetic activity.[7,8]
Cucumis metuliferus (Cucurbitaceae) is a monocious, climbing, 
annual herb that can be grown practically anywhere, provided 
the season is warm.[9] It flowers from July to September 
and the fruit ripens from October to December.[10]
Many herbal practitioners on the plateau and environs 
use C. metuliferus fruit for the treatment of many ailments, 
including diabetes mellitus, hypertension, and typhoid fever. 
The fruit and leaves of this plant are widely consumed as 
a source of vegetables, with high nutritional values.[11] The 
anthelmintic properties of the plant seeds have also been 
documented.[12]
In the present study, we investigated the antidiabetic activity 
INTRODUCTION
Diabetes Mellitus (DM) is an endocrine metabolic disorder 
in which the body does not produce sufficient insulin or 
lack of responsiveness to insulin, resulting in hyperglycemia 
(high blood glucose level). The classical symptoms include 
polyuria, polydipsia, weight loss, lethargy, polyphagia, visual 
blurring, frequent or recurring infections, cuts and bruises 
that are slow to heal, tingling and / or numbness in hands 
and / or feet, drowsiness, nausea, and decreased endurance 
during exercise.[1,2]
Despite the advancement in the understanding and 
management of DM, the incidence of the disease continues 
to increase.[3,4] More rural diabetic patients are now relying 
much more on traditional remedies,[5,6] due to the frequent 
claims by herbal medicine practitioners with regard to the 
Pharmacology
Evaluation of the Hypoglycemic Activity of Cucumis metuliferus 
(Cucurbitaceae) Fruit Pulp Extract in Normoglycemic and Alloxan-
Induced Hyperglycemic Rats
Jimam NS, Wannang NN1, Omale S, Gotom B1
Departments of Clinical Pharmacy and 1Pharmacology, Faculty of Pharmaceutical Sciences, 
University of Jos, Jos, Nigeria
Address for correspondence: Nanloh S. Jimam; E-mail: jimams@unijos.edu.ng
ABSTRACT
The hypoglycemic effects of the fruit extract of C. metuliferus was investigated in normoglycemic and alloxan-
induced hyperglycemic rats. The results showed that there was an insignificant (P > 0.05) decrease in the blood 
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From this study, the data suggested that the fruit extract did not alter the BGC level in normoglycemic rats, but 
had a potential hypoglycemic property in alloxan-induced hyperglycemic rats.
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The ripe fruits of the non-bitter form of C. metuliferus 
were collected from Farin Gada and Babale area of Jos, 
Plateau State, Nigeria, in September, 2008. The whole 
plant and fruits were identified and authenticated by Prof. 
D. L. Wonang of the Department of Botany, University 
of Jos, Nigeria.
Preparation of the extract
The ripe fruits collected from the plant were cut transversely 
using a blade, and the mesocarp contents were carefully 
scooped out from the pericarp with the aid of a spatula. 
The fleshy content was blended using an electric blender 
and the fluid product of the blending was passed through 
a sieve to separate the seeds from the juicy contents. The 
smooth filtrate was evenly spread on an aluminium tray 
and dried in a drying cabinet, at about 58oC until the liquid 
content had evaporated. The resultant product was air 
dried for several hours and then pounded to powder using 
a mortar and pestle. The powder was weighed and stored 
at room temperature in an air tight bottle, prior to use.
Chemicals
Alloxan monohydrate (B. D. H. Laboratories, Chemical 
Division Poole, England) and Tolbutamide powder 
(Hoechst Fedco Pharma Ltd.) were used.
Experimental animals
The Wister strains of male albino rats weighing between 
150 – 240 g were obtained from the animal House of the 
University of Jos, Nigeria. They were fed with standard 
food (Pfizer Feed, Lagos) and water ad libitum.
Activity of the extract in normoglycemic rats
Twenty-five (25) young, healthy, male albino rats were 
divided into five groups of five rats each. The baseline 
blood glucose concentration levels of the overnight fasted 
rats were measured before administration of the fruit 
extract. The control animals received equi-volume of 
distilled water (group 1), while the reference group (group 
2) received 200 mg/kg of tolbutamide, through the oral 
route. Groups 3, 4, and 5 were orally administered 500, 
1000, and 1500 mg/kg doses of C. metuliferus fruit extract, 
respectively.
After treatment, the blood glucose concentration (BGC) 
levels of the rats were measured at half, 1, 2, 4, 8, and 
12 hours. The BGC levels were determined using the 
glucose-oxidase peroxidase method (Glucose assay kit) as 
expressed in mg/dl.
Activity of the extract in alloxan-induced hyperglycemic 
rats
Twenty-five male Wister strains of the overnight fasted 
albino rats were made hyperglycemic by injecting alloxan 
monohydrate dissolved in distilled water at a dose of 120 
mg/kg body weight, via the intraperitoneal route. After one 
hour of alloxan administration, the rats were given food and 
water ad libitum. The blood glucose concentration levels of 
the rats was measured after 72 hours of alloxan injection 
using a glucose assay kit, to determine the presence and 
level of hyperglycemia.
Animals in groups 1 and 2 were administered distilled 
water and 200 mg/kg tolbutamide, respectively. Animals 
in groups 3, 4, and 5 were treated with 500, 1000, and 1500 
mg/kg dose of the extract, respectively. After treatment, the 
blood glucose concentration level was measured at half, 1, 
2, 4, 8, and 12 hours using the glucose assay kit.
Statistical analysis
Data obtained were subjected to one way ANOVA followed 
by the student’s t-test to determine the level of significance 
at P < 0.05 probability level.
RESULTS
The oral administration of graded doses (500, 1000, 
and 1500 mg/kg) of C. metuliferus fruit extract produced 
insignificant (P > 0.05) transient decrease in BGC (blood 
glucose concentration), in normoglycemic rats, at dose 
points of 1000 and 1500 mg/kg, as shown in Table 1.
From Table 2, it can be seen that graded doses (500, 1000, 
and 1500 mg/kg) of C. metuliferus fruit extract produced 
a significant (P < 0.05) decrease in BGC levels in alloxan-
induced hyperglycemic rats when compared to the control 
hyperglycemic rats.
DISCUSSION
The extract produced a significant decrease in glucose Jimam, et al. J Young Pharm. 2010;2(4): 384-387
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levels in the alloxan-induced rats and an insignificant 
decrease in the normal rats [Tables 1 and 2]. It is possible 
that the fruit extract improved the ability of the animals 
to utilize the external glucose load, a mechanism of 
action similar to that of the standard reference drug 
(tolbutamide), a sulfonylurea.[13] Sulfonylurea compounds 
produce hypoglycemia in normal animals by stimulating 
the pancreatic beta-cells to produce more insulin and by 
increasing the glycogen deposition in the liver, but are not 
effective in alloxan-induced diabetic animals because alloxan 
treatment causes a permanent destruction of the beta-
cells.[14] In this study, a contrary result was obtained. The 
extract did not decrease the BGC levels in normoglycemic 
rats, but decreased it in hyperglycemic rats. This implies 
that in addition to the mechanism mentioned above, it is 
possible that other mechanisms are also involved. On the 
other hand, as exogenously administered insulin produces 
hypoglycemia in both normal and alloxan-induced diabetic 
subjects,[14,15] it would seem reasonable to suggest that the 
hypoglycemic principles in the C. metuliferus fruit extract 
exert a direct effect on diabetic rats, in a fashion similar 
to insulin. It has also been documented that saponin 
glucosides have a glucagon lowering effect,[16] which may 
enhance glucose utilization as indicated by the increase in 
hepatic glycogen. The presence of phytochemical materials, 
which may be responsible for the pharmacological activity 
has been shown by Jimam in 2008.[17]
CONCLUSION
Oral treatment of experimental rats with C. metuliferus 
fruit extract caused significant (P < 0.05) reduction in 
the blood glucose level in alloxan-induced hyperglycemic 
rats, although there was no significant effect on the 
normoglycemic rats.
Though our results seem to justify the claim of the 
traditional healers, work is on-going to confirm the 
hypoglycemic activity of constituents and to evaluate its 
potential in the treatment of diabetes mellitus.
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